About Simcere Pharma
Simcere Pharma is a publicly listed company based in Nanjing (China) founded in 1995. Novel oncology and immunology therapeutics are developed and commercialized. The company has 6,580 employees. Its website simcere.com draws about 10 thousand monthly visits. Simcere Pharma offers products and services including Anti-tumor Drugs and Nervous System Drugs. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Jiangsu Simcere Pharmaceutical Co., Ltd.
Company details
Simcere Pharma was founded in 1995 and is headquartered in Nanjing, China, within the pharmaceutical sector. Research, development, and commercialization of treatments for cancer and autoimmune diseases are conducted. The pipeline features antibody-drug conjugates and biologics directed at disease-specific pathways. Manufacturing and distribution networks are maintained to support products, and research partnerships are formed to advance therapy timelines for patients.
- Headquarters Nanjing, China
- Employees 6,580
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website simcere.com
- Social LinkedIn X Facebook
- Legal Name Simcere Pharmaceutical Group Limited
- Annual Revenue$1.08 B (USD)16.55as on Dec 31, 2025
- Net Profit$187.56 M (USD)86.2as on Dec 31, 2025
- EBITDA$224.82 M (USD)33.52as on Dec 31, 2025
- Employee Count6,580
Products & Services of Simcere Pharma
Simcere Pharma offers a comprehensive portfolio of products and services, including Anti-tumor Drugs and Nervous System Drugs.
Anti-tumor drugs are developed and marketed by Simcere for various cancer treatments.
Nervous system drugs are provided by Simcere for conditions like insomnia and related disorders.
People of Simcere Pharma
27 people are tracked at Simcere Pharma (17 in leadership, 10 in team); the tracked headcount is 6,580.
| Name | Role | Group |
|---|---|---|
Ren Jinsheng | Chairman and CEO | Leadership |
Chen Chen | VP - Head Of Business Development China/apac | Leadership |
Agnes Ho | Head Of Regulatory Affairs | Leadership |
Iris Gao | Manager & Executive Assistant To Cho/executive Director | Leadership |
Annie Tan | General Manager, International Business | Leadership |
Jin Zhang | Deputy Director In CNS | Leadership |
Hong Qi | Executive Director | Leadership |
Stewart Leung | Senior Director | Leadership |
Fiona Qiu | Director Of Finance | Leadership |
Ting Ye | Head Of Procurement & Supply Chain Management | Leadership |
Feng Wang | Vice President | Leadership |
Jian Shao | Head Of Investment | Leadership |
Lois Liu | Head Of Finance, Boston Innovation Center And International Business | Leadership |
Yu Wan | Senior IT Director | Leadership |
Carrie Chen | Head Of Operations & Senior Director, Human Resources, US & EU | Leadership |
Ping Liu | TA Head In Neurology | Leadership |
Xinxin Li | Senior Director Of Analytical And Formulation (biologics) | Leadership |
Alex Darwin | International Sales Consultant | Team |
Rosie Jiang | Recruiting Manager | Team |
Wenny Z. | Executive Associate, Clinical Development | Team |
7 more people are available in the full profile.
Complete people profiles for Simcere Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Simcere Pharma
Simcere Pharma is a publicly listed company on the HKEX with ticker symbol 2096 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Oct 2020
- Listed onHKG: 2096
- Listed entitySimcere Pharmaceutical Group Limited
- Exchange sectorHealth technology
- ISINHK0000658531
- Share price10.90 HKD (+1.68% on the day) · 2026-10-14
- Market capitalisation27,531,088,459.00 HKD
- Price to earnings15.8
- EPS (diluted, trailing year)0.69 HKD
- Dividend yield1.9%
- Volume (last session)1,730,000
Financials of Simcere Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 8.38B HKD | 1.46B HKD | 1.75B HKD |
| 2024 | 7.19B HKD | 782.8M HKD | 1.31B HKD |
| 2023 | 7.30B HKD | 789.8M HKD | 943.9M HKD |
| 2022 | 7.35B HKD | 1.08B HKD | 834.0M HKD |
| 2021 | 6.03B HKD | 1.82B HKD | 404.5M HKD |
Detailed financial statements for Simcere Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Simcere Pharma
The website of Simcere Pharma (simcere.com) receives about 10.3K visits a month and ranks #1,946,876 among all websites worldwide, #2,647 in Biotechnology and Pharmaceuticals.
- Monthly visits10.3K
▼ 19.3% vs previous month
- Unique visitors5.6K
per month
- Global rank#1,946,876
among all websites
- Category rank#2,647
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.6
- Average visit11 sec
- DevicesDesktop 45% · Mobile 55%
Websites whose visitors overlap most with Simcere Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hrs.com.cn | 100% | View details | |||
pfizer.com.cn | pfizer.com.cn | 99% | #2,133,174 | – | |
daiichisankyo.com.cn | daiichisankyo.com.cn | 94% | #4,602,091 | – | |
msdchina.com.cn | msdchina.com.cn | 88% | #4,167,479 | – | |
| pharmcube.com | 88% | 524.7K | #93,712 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Simcere Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Simcere Pharma
Complete news archive for Simcere Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simcere Pharma
Simcere Pharma was founded in 1995.
Simcere Pharma is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Simcere Pharma has 6,580 employees.
Annual revenue of Simcere Pharma is $1.08B as on Dec 31, 2025.
Simcere Pharma was founded in 1995 and is headquartered in Nanjing, China, within the pharmaceutical sector. Research, development, and commercialization of treatments for cancer and autoimmune diseases are conducted. The pipeline features antibody-drug conjugates and biologics directed at disease-specific pathways. Manufacturing and distribution networks are maintained to support products, and research partnerships are formed to advance therapy timelines for patients.
Simcere Pharma offers Anti-tumor Drugs and Nervous System Drugs.
Yes, Simcere Pharma is publicly traded on HKEX under the ticker symbol 2096.
Simcere Pharma operates through Jiangsu Simcere Pharmaceutical Co., Ltd.